Title: Scientific and Operations Consultant
Company: Rare Cancer Research Foundation
Location: Oakland, California, United States
John Major, scientific and operations consultant at the Rare Cancer Research Foundation, has been recognized by Marquis Who’s Who Top Scientists for dedication, achievements, and leadership in bioinformatics, clinical operations, and bioinformatics consulting.
With over two decades of experience to his credit, Mr. Major has excelled as a leader in the fields of bioinformatics, clinical operations, and informatics consulting. Beginning as a graduate research assistant and scientific diver at Northeastern University from 1998 to 2000, he transitioned to roles such as scientific programmer at the Whitehead Institute for Biomedical Research from 2001 to 2005. His expertise in bioinformatics led him to pivotal positions at institutions like the Eli and Edythe Broad Institute of MIT and Harvard and Memorial Sloan-Kettering Cancer Center.
Joining Invitae Corp. in 2011, Mr. Major played key roles in various capacities, including director of clinical laboratory operations and principal research scientist and engineer from 2011 to 2022. His contributions were instrumental in the company’s growth and transition to a public entity. More recently, he founded Daylily Informatics and has served as a clinical diagnostic operations and informatics consultant at Naveris since 2022, showcasing his commitment to innovation and entrepreneurship.
In light of his impressive undertakings, Mr. Major has accrued several accolades throughout his career, including being recognized as a key contributor to Invitae Corp.’s growth and transition to a public company. He has also presented posters and spoken at national conferences, showcasing his expertise and influence in the field. In addition to his professional endeavors, his involvement in the Burning Man community and contributions to the open-source software community underscore his diverse interests and collaborative spirit. In the coming years, Mr. Major aspires to continue eliminating operational roadblocks in clinical diagnostics while contributing to a positive global impact through innovation and collaboration.
For more information, please visit:
Contact Mr. Major: